Fulphila

Random entry RSS

Posted in:
News

U.S. FDA Approves First Biosimilar to Neulasta
By Andrew Storaska June 29, 2018 Comments are off
Earlier this month, the U.S. FDA announced approval of Mylan’s Fulphila biosimilar to Neulasta® (pegfilgrastim). Neulasta® was...

Read more

Tagged with: Amgen, Biocon, EMA, FDA, Fulphila, Mylan, Neulasta®, pegfilgrastim

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top